CNCE Shares Outstanding History



Below is a table of the CNCE shares outstanding history going back to 2/13/2014:

Date CNCE Shares Outstanding
2/13/201416.22M
3/28/201417.90M
5/13/201417.90M
8/4/201418.01M
11/6/201418.19M
2/23/201518.29M
5/6/201521.72M
7/31/201521.92M
10/30/201522.08M
2/23/201622.20M
4/29/201622.22M
8/3/201622.23M
11/3/201622.27M
2/27/201722.33M
4/28/201722.56M
8/4/201722.69M
11/6/201722.77M
2/26/201823.23M
5/1/201823.40M
7/30/201823.42M
10/29/201823.43M
2/22/201923.53M
4/30/201923.80M
7/26/201923.80M
11/4/201923.84M
2/21/202029.64M
4/24/202029.65M
7/31/202029.68M
10/30/202030.65M
2/19/202132.17M
4/26/202132.17M
7/31/202132.17M
11/5/202134.66M
2/28/202234.95M
5/2/202236.33M
8/1/202247.93M
11/1/202247.94M

Also see: CNCE Market Cap History
CNCE YTD Return
CNCE Historical Shares Outstanding:
+13.24% CAGR
CNCE Historical Shares Outstanding: +13.24% CAGR

Mouse over chart for data details
2/13/2014 ...11/1/2022
Concert Pharmaceuticals is a late-stage clinical biopharmaceutical company that is developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 inhibitor that Co. discovered through the application of its DCE Platform® (deuterated chemical entity platform). Co. is evaluating CTP-543 in a Phase 3 clinical program for the treatment of alopecia areata, a serious autoimmune dermatological condition. In addition to its wholly-owned development programs, Co. has entered into collaborative arrangements with companies to develop deuterium-modified versions of their marketed products. We show 37 historical shares outstanding datapoints in our coverage of CNCE's shares outstanding history.

Understanding the changing numbers of CNCE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CNCE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CNCE by allowing them to research CNCE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CNCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Concert Pharmaceuticals (CNCE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CNMD Shares Outstanding History
CNSP Shares Outstanding History
CNST Shares Outstanding History
CNTX Shares Outstanding History
CNVY Shares Outstanding History
COCP Shares Outstanding History
CODX Shares Outstanding History
COGT Shares Outstanding History
COLL Shares Outstanding History
COM Shares Outstanding History
More Healthcare companies »

 

CNCE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.